Trends in cancer
ISSN 2405-8025 · Elsevier BV · United States · active 2015–2026
Metrics
- Scimago quartile (2025)
- Q1
- Cites per paper (2y)
- 10.9
- SJR
- 5.488
- h-index
- 140
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric (how the two differ). Citation rates differ enormously between fields, so compare within a discipline. What the other figures mean: journal quartile, SJR, h-index and article processing charge.
Data as of 18 October 2026 (venue index build).
Scimago Journal Rank 2025
In the Scimago Journal Rank 2025 edition, Trends in cancer is Q1 in all 2 of its subject categories.
| Subject category | Quartile | Rank in category |
|---|---|---|
| Cancer Research | Q1 | #10 of 235 |
| Oncology | Q1 | #15 of 426 |
- Cites per document (2 years, Scopus)
- 13.84
- Documents indexed in 2025 (Scopus)
- 119
The quartile is the one Scimago prints for each category. Rank is the journal's position by SJR among the journals Scimago lists in that category (#1 is the highest); “—” means we hold no rank consistent with that quartile. The document count is what Scopus indexed that year, which can be lower than a journal's full output. Source: SCImago Journal Rank 2025 edition, from Scopus data (scimagojr.com, CC BY-NC).
Trends in cancer is Q1 in all 2 of its Scimago subject categories (2025 edition; best category Cancer Research: Q1, #10 of 235), with SJR 5.488 (Scimago) and an h-index of 140 (OpenAlex). Listed in Scopus, Web of Science, PubMed.
Is this the right journal for your paper?
The AI Journal Finder ranks the best-matched journals for your paper’s topic — with tier, open access, citation rate and predatory flags. Free to start.
Responding time
- Submission to acceptance
- 65 days (median)Publisher-reported
Turnaround figures are indicative, not a guarantee: DOAJ values are self-reported by the journal (average weeks, submission to publication); library estimates are medians of the received/accepted dates printed in papers we hold. Editorial times vary by article type and season — confirm on the journal’s own site.
Indexing & access
- Indexed in
- ScopusWeb of SciencePubMed
- Access status:
- hybrid. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Trends in cancer a predatory journal?
Our screening does not flag Trends in cancer. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is Trends in cancer indexed in Scopus or Web of Science?
Per our venue index, Trends in cancer appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is the impact factor of Trends in cancer?
Papers in Trends in cancer are cited about 10.9 times each within two years of publication, and Scimago places it in Q1, with an h-index of 140. Those are the open equivalents: the Clarivate Journal Impact Factor is a proprietary metric we neither compute nor license, so we show the two-year citation rate and Scimago quartile instead — they answer the same question of how heavily the journal is cited. A citation rate is a property of a field as much as of a journal.
What Scimago quartile is Trends in cancer (Q1, Q2, Q3, or Q4)?
In the Scimago Journal Rank 2025 edition, Trends in cancer is Q1 in all 2 of its subject categories. By category: Cancer Research: Q1, #10 of 235; Oncology: Q1, #15 of 426. Quartiles split the journals in a subject category into four equal groups by SJR, so Q1 is the most-cited quarter and Q4 the least; Trends in cancer is cited about 10.9 times per paper over two years, with an h-index of 140.
What is the Web of Science (JCR) quartile of Trends in cancer?
The Web of Science quartile comes from Clarivate's Journal Citation Reports (JCR), a proprietary product we neither license nor compute — so we cannot state a JCR quartile for Trends in cancer. The open equivalent is its Scimago quartile, Q1, derived from Scopus citation data. Because JCR ranks against Web of Science and Scimago against Scopus, the two can differ, so check Clarivate's site directly if you need the JCR quartile specifically.
Is Trends in cancer open access?
Our index records its access status as "hybrid". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.
How long does Trends in cancer take to publish a paper?
Submission to acceptance for Trends in cancer takes about 65 days (median) — Publisher-reported. Treat it as indicative rather than a guarantee: editorial times vary by article type, reviewer availability and season, and a self-reported figure is the journal's own. We do not hold a peer-review acceptance rate for Trends in cancer.
Ready to submit? Tools for your next paper
Similar venues
- Cancer and Metastasis ReviewsQ1 · Springer Science+Business Media
- Seminars in Cancer BiologyQ1 · Elsevier BV
- Cancer Treatment ReviewsQ1 · Elsevier BV
- Journal for ImmunoTherapy of CancerQ1 · BMJ
- Journal of Cancer SurvivorshipQ1 · Springer Science+Business Media
- Applied immunohistochemistry & molecular morphologyQ2 · Lippincott Williams & Wilkins
Compare it with its peers: Ranked Oncology journals — ranked by Scimago quartile and cites per paper, predatory venues excluded.